EUVIMEDEUVIMED entdecken
Open Access

Click-to-Release: Cleavable Radioimmunoimaging with [ 89 Zr]Zr-DFO- Trans -Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio

Maria Vlastara, Raffaella Rossin, Freek J M Hoeben, Kim E de Roode, Milou Boswinkel, Laurens H J Kleijn, James Nagarajah, Mark Rijpkema, Marc S Robillard

Theranostics · 2023

DOI: 10.7150/thno.84865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Maria Vlastara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Radioimmunodetection, Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadioimmunodetectionNeoplasmsAnimalsMiceTrastuzumabAntibodies, MonoclonalPositron-Emission TomographyCyclooctanesCell Line, TumorZirconium

Stichwörter der Autor:innen

IEDDAclick-to-releaseradioimmunoimagingtrans-cyclooctenetrastuzumab

Substanzen

TrastuzumabAntibodies, MonoclonalCyclooctanesZirconium

Autor:innen und Institutionen

  • Tagworks Pharmaceuticals, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
  • SyMO-Chem, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.

Zitieren

APA

Vlastara, M., Rossin, R., Hoeben, F. J. M., de Roode, K. E., Boswinkel, M., Kleijn, L. H. J., Nagarajah, J., Rijpkema, M., & Robillard, M. S. (2023). Click-to-Release: Cleavable Radioimmunoimaging with [ 89 Zr]Zr-DFO- Trans -Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio. Theranostics. https://doi.org/10.7150/thno.84865

Vancouver

Vlastara M, Rossin R, Hoeben FJM, de Roode KE, Boswinkel M, Kleijn LHJ, et al. Click-to-Release: Cleavable Radioimmunoimaging with [ 89 Zr]Zr-DFO- Trans -Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio. Theranostics. 2023. doi:10.7150/thno.84865

BibTeX
@article{Vlastara2023,
  author = {Vlastara, Maria and Rossin, Raffaella and Hoeben, Freek J M and de Roode, Kim E and Boswinkel, Milou and Kleijn, Laurens H J and Nagarajah, James and Rijpkema, Mark and Robillard, Marc S},
  title = {Click-to-Release: Cleavable Radioimmunoimaging with [ 89 Zr]Zr-DFO- Trans -Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.84865}
}
Kostenlos starten →